Skip to content

Value of Additional Upfront Systematic Lung Ultrasound in the Workup of Patients With Unilateral Pleural Effusion

Value of Additional Upfront Systematic Lung Ultrasound in the Workup of Patients With Unilateral Pleural Effusion: A Prospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04235998
Enrollment
57
Registered
2020-01-22
Start date
2020-02-17
Completion date
2021-05-06
Last updated
2022-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Pleural Effusion, Pleural Effusion, Ultrasound

Brief summary

The value of lung ultrasound in the work up of pleural effusion (fluid in between the thin doublet layered film surrounding the lungs) is unknown. The researchers will perform a systematic lung ultrasound scan including a scan for extra thoracic metastasis (spread of cancer to other organs) in the lymphnodes of the neck and metastasis lever in 56 patients one-sided pleural effusion. The researchers will measure if the interventions change the diagnostic plan for the patient and leads to faster diagnostics of the underlying course.

Interventions

DIAGNOSTIC_TESTSystematic lung ultrasound

Patients will undergo a systematic lung ultrasound including review of: * Sonographic characteristic of effusion * Parietal, diaphragmatic and visceral pleura * Pleural nodules * Lung parenchyma * Extra pulmonary findings: Hepatic pathology, enlarged lymph nodes of the neck and a cardiac assessment.

Sponsors

Naestved Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years. * Unilateral pleural effusion of unknown course. * Patients must be able to give informed consent.

Exclusion criteria

* Bilateral pleural effusions. * Known cause of pleural effusions. * Life expectancy \<3 months. * Inability to understand written or spoken Danish.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of cases where systematic lung ultrasound (LUS) change the planned diagnostic process for patients with unilateral pleural effusion.26 weeks post procedureInformation found in electronic patient files. Comparison of diagnostics planned before systematic ultrasound and diagnostics planned after systematic ultrasound. Measured in proportion of included patients

Secondary

MeasureTime frameDescription
Proportion of cases where findings of clinical importance on systematic LUS were not identified at the initial contrast-enhanced CT thorax or PET-CTDay 1 within 30 minutes after the end of procedureCT thorax and PET-CT (as assessed by radiologist or clinician at the initial planning of diagnostic work-up)
Proportion of cases where the change in the diagnostic process after LUS provide a diagnose26 weeks post procedureInformation found in electronic patient files.
The patient experienced pain during procedure scoreDay 1 within 30 minutes after the end of procedureMeasured by a VAS (Visual Analogue Scale) scale 0-10, 0 being no pain, 10 being the worse pain
Characteristics of ultrasonic findings with additional systematic LUS.Day 1, within 30 minutes after the end of procedureCharacteristics is recorded in the ultrasound protocol
The patients willingness to have the same examination again in the future if necessaryDay 1within 30 minutes after the end of procedureMeasured by a 5-point Likert scale, scale 1-5, 1 being definitely willing to have the examination again, 5 being definitely not willing to have the examination again
Mean extra time spend on systematic LUS compared to conventional US for guidance of thoracentesisDay 1 within 30 minutes after the end of procedureMeasured in minutes.
Patient experienced time consumptionDay 1 within 30 minutes after the end of procedureMeasured by a 3-point Likert scale , scale1-3, 1 being not time consuming at all, 3 being very time consuming

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026